Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to ‘pursue other opportunities.’ Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.
Says Executive Chair & former CEO Said Darwazah will assume all CEO responsibilities. Darwazah was named chair in May 2014, and was previously chair and CEO of Hikmas group holding company until 2003 from 1994.
Notes it has initiated an externally facilitated process to find a new CEO.
Current stock price: 1,755.00 pence
12-month change: down 30%
Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.